174 related articles for article (PubMed ID: 8641643)
1. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
[TBL] [Abstract][Full Text] [Related]
2. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
[TBL] [Abstract][Full Text] [Related]
3. [Improvement of anemia by recombinant human erythropoietin in paroxysmal nocturnal hemoglobinuria].
Ikeda Y; Yoshinaga K; Iki S; Ohbayashi Y; Urabe A
Rinsho Ketsueki; 1993 Sep; 34(9):1022-6. PubMed ID: 8230745
[TBL] [Abstract][Full Text] [Related]
4. High-dose recombinant human erythropoietin and low-dose corticosteroids for treatment of anemia in paroxysmal nocturnal hemoglobinuria.
Bourantas K
Acta Haematol; 1994; 91(2):62-5. PubMed ID: 8023644
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
[TBL] [Abstract][Full Text] [Related]
6. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
7. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
Faller B; Slingeneyer A; Waller M; Michel C; Grützmacher P; Müller HP; Barany P; Grabensee B; Issad B; Schmitt H
Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog.
Koumegawa J; Kawahara J; Kubo K; Amano K; Wakimoto N; Takahashi K; Juji T; Takaku F
Int J Cell Cloning; 1990 Mar; 8(2):97-106. PubMed ID: 2313141
[TBL] [Abstract][Full Text] [Related]
10. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
11. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
13. Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy.
Bencaiova G; Krafft A; Burkhardt T; Breymann C
Acta Haematol; 2006; 116(4):259-65. PubMed ID: 17119327
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in the treatment of postpartum anemia.
Huch A; Eichhorn KH; Danko J; Lauener PA; Huch R
Obstet Gynecol; 1992 Jul; 80(1):127-31. PubMed ID: 1603482
[TBL] [Abstract][Full Text] [Related]
15. [Successful cholecystectomy in a patient with paroxysmal nocturnal hemoglobinuria].
Matsuda S; Ohkoshi T; Kanbayashi H; Tanaka T; Sakuma H; Shiga Y; Shichishima T; Maruyama Y
Rinsho Ketsueki; 1991 Nov; 32(11):1515-20. PubMed ID: 1758063
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria.
Boschetti C; Fermo E; Bianchi P; Vercellati C; Barraco F; Zanella A
Am J Hematol; 2004 Sep; 77(1):36-44. PubMed ID: 15307104
[TBL] [Abstract][Full Text] [Related]
17. Therapy of anemia in patients with multiple myeloma.
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Acta Med Austriaca; 1995; 22(4):59-64. PubMed ID: 8835422
[TBL] [Abstract][Full Text] [Related]
18. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
